Embracing the Unknown

Researchers are showing that ambiguity can be essential to brain development.

Written byJamie Holmes
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

CROWN, OCTOBER 2015Scholars have sliced and diced the terms “ambiguity,” “uncertainty,” and “ignorance,” among others, in a variety of different ways. Oftentimes, the usefulness of these sharp lines isn’t plainly apparent. But one dividing line between types of unknowns that has recently led researchers to fascinating new biological insights is the distinction between risk and ambiguity. According to decision theorists, risky choices are those where the specific outcome isn’t known while the odds of success are. Think of flipping a coin. You’re certain of the probability of its landing on heads or tails, but you can’t predict the outcome of any particular toss. Ambiguous choices are those whose odds of success are unknown because the rules determining the outcome are unclear.

This important distinction between ambiguity and risk is one that I explore in my book, Nonsense: The Power of Not Knowing.

Economic theorist Daniel Ellsberg’s famous thought experiment illustrates the contrast. Say you have to pick out a ball from one of two urns, both containing black and red balls. Each urn contains one hundred balls. Pull out a red ball, and you’ll win a hundred dollars. Pick a black one, and you’ll get zilch. But the two urns are different. Urn 1 holds anywhere from zero to one hundred red balls and from zero to one hundred black ones. Urn 2 has fifty black balls and fifty red balls. Ellsberg realized that if you ask people whether they’d prefer to bet on pulling from ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies